top of page
Latest News from Pro PG


Shortage of NYXOID naloxone hydrochloride dihydrate 2.2 mg/actuation nasal spray vial
Historical supply notice: This article relates to a previous medicine shortage or regulatory approval. Availability and regulatory status may have changed. Healthcare professionals should contact Pro Pharmaceuticals Group to confirm the current supply position. For current Australian shortage and supply information, see medicine shortages in Australia. Dear Healthcare Professional, Shortage of NYXOID naloxone hydrochloride dihydrate 2.2 mg/actuation nasal spray vial (AUST R:
Jun 15, 2023


The Power of Active Pharmaceutical Ingredients (APIs) and Their Impact on Drug Shortages
Introduction: In the realm of healthcare, drug shortages have become a growing concern, impacting patients, healthcare providers, and pharmaceutical companies alike. One crucial factor that contributes to these shortages is the power dynamics associated with Active Pharmaceutical Ingredients (APIs). In this blog post, we will explore the role of APIs in the pharmaceutical industry and discuss how the Porter's Five Forces framework can shed light on their significance within..
Jun 5, 2023
bottom of page